For the metilene-based outcomes, SALL1 (Spalt Like Transcription Factor 1) was found to give the strongest indication for a predictive biomarker out of the female cohort with the combination of all 3 cancers and a cutoff of 8, see Table 4. The gene discussed is SALL1; the disease is cancer.